JPRN-UMIN000001979未知2 期
Phase II study of a combined Paclitaxel, Gemcitabine, and Cisplatin chemotherapy regimen for advanced urothelial carcinoma - Phase II study of a TGP chemotherapy regimen for advanced urothelial carcinoma
Cancer Institute Hospital, Japanese Foundation for Cancer Research0 个研究点目标入组 30 人开始时间: 2009年5月18日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •no other active malignancy Acute myocardial infarction within 3 months of this study
研究者
相似试验
已完成
2 期
A combination phase II study of paclitaxel and gemcitabine for recurrent or relapsed non-small cell lung cancer previously treated with platinum or docetaxel-based regimenon-small cell lung cancerJPRN-C000000219West Japan Oncology Group80
已完成
不适用
Phase 1/2 study of weekly paclitaxel and gemcitabine in patient with HER2 negative recurrent breast cancerBreast CancerJPRN-UMIN000008848Hiroshima Breast Cancer Study Group45
已完成
2 期
Phase II study of Gemcitabine + nab-paclitaxel as first-line therapy for locally advanced pancreatic cancerlocally advanced unresectable pancreatic cancerJPRN-UMIN000016852Kurume university school of medicine24
已完成
2 期
A phase 2 study of weekly Paclitaxel plus Gemcitabine Combination Chemotherapy in Patients with advanced or metastatic Breast CancerBreast CancerJPRN-UMIN000004741Kinki Multidisciplinary Breast Oncology Group35
已完成
不适用
A phase II study of gemcitabine and nab-paclitaxel followed by chemoradiotherapy with S-1 in patients with locally advanced pancreatic cancerJPRN-UMIN000026525Chiba Cancer Center30